Our Vision: MicroVention’s goal is to be the leading global neurovascular company. We will accomplish this goal by producing the most reliable, easiest to use and most technologically advanced products supported by proven clinical data.
Internet Explorer users: This website is best viewed with Compatibility Mode disabled. You may need to change your setting to view this site.
MICROVENTION & SEQUENT MEDICAL
Terumo Corporation Acquires Sequent Medical: MicroVention Gains Developer of New Aneurysm Embolization Device
TERUMO ACQUIRES SEQUENT MEDICAL
Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device
- Accelerating Growth in Neurovascular Treatent -
SNIS 2016 - Boston, MA
July 25-29, 2016. Come visit us during the meeting.